VYNE Therapeutics Inc. (YARW)

CIK 1566044 · operating company. SEC filings, financial statements, 10-K sections, 8-K items and insider trades for VYNE Therapeutics Inc..

Recent SEC filings

FiledFormAccession number
Oct 30, 202640001104659-26-120647
Oct 30, 202640001104659-26-120657
Oct 30, 202640001104659-26-120656
Oct 30, 202640001104659-26-120652
Oct 30, 202640001104659-26-120654
Oct 7, 2026SCHEDULE 13G0001104659-26-114282
Sep 17, 2026SCHEDULE 13G0002005369-26-000053
Sep 14, 20268-K0001104659-26-107485
Sep 11, 2026424B50001104659-26-107102
Sep 11, 2026424B50001104659-26-107112
Sep 10, 20268-K0001104659-26-106699
Aug 19, 2026EFFECT9999999995-26-002706
Aug 14, 2026SCHEDULE 13G0000905148-26-003761
Aug 14, 2026SCHEDULE 13G0001104659-26-097426
Aug 14, 2026POS AM0001104659-26-096109
Aug 13, 202610-Q0001566044-26-000010
Aug 13, 20268-K/A0001104659-26-095925
Aug 13, 2026SCHEDULE 13G/A0002140685-26-000004
Aug 7, 2026SCHEDULE 13G0001274173-26-000185
Aug 7, 2026SCHEDULE 13G/A0000935836-26-000377
Aug 5, 2026SCHEDULE 13D0000947871-26-000747
Aug 4, 2026SCHEDULE 13G0000935836-26-000371
Aug 3, 2026SCHEDULE 13G0001193125-26-330498
Jul 30, 202630001104659-26-088658
Jul 30, 2026SCHEDULE 13G0001104659-26-088671